72.04 Adrenal Incidentaloma Follow-up is Influenced by Patient, Radiological and Medical Provider Factors

D. I. Maher1, E. Williams1, S. Grodski1,2, J. W. Serpell1,2, J. C. Lee1,2  1Alfred Hospital,Monash University Endocrine Surgery Unit,Melbourne, VIC, Australia 2Monash University,Department Of Surgery,Melbourne, VIC, Australia

Introduction: The majority of adrenal incidentalomas (AI) are benign, although some are large, functional or malignant, and may require surgery. Therefore, all require follow-up. This case-control study aims to determine the pattern of AI follow-up in a level 1 trauma centre in Melbourne Australia, focussing on the factors that influence whether follow-up is facilitated.

Methods: Patients with CT-detected AIs between January 2010 and September 2015 at The Alfred Hospital were included. Case files were identified using a key word search of electronic CT reports. Patients were excluded if the primary purpose of the CT was to investigate adrenal disease, or if the patient had a history of known adrenal mass. Cases were assessed by two authors and reviewed for demographics, managing unit, CT indication and findings, and follow-up arrangements. To consistently determine if “follow-up” occurred, a strict definition of the term was applied. Statistical analysis using t-test, Chi-squared test and logistic regression was performed using Stata SE v14, with a p-value of < 0.05 set as significant.

Results: A total of 38 848 chest and abdominal CTs were performed in the study period, yielding 804 patients with AIs who met inclusion criteria (mean age 65, 58 % male). The mean size of AI was 23 mm. Univariate analysis demonstrated that follow-up was more likely to occur in younger patients (mean age 62 vs 66, p < 0.001); in larger lesions (mean size 26 mm vs 21 mm, p < 0.001); if the CT suggested follow-up (p < 0.001); or if the CT report suggested a diagnosis (p < 0.001). Follow-up arrangements were most likely to be made by the trauma unit (39 %, p = 0.01).

A multivariable analysis supported the significance of these findings and indicated that the CT report and managing unit strongly influence follow-up rates. When a diagnosis was suggested by the CT report, follow-up was more likely to be facilitated (odds ratio 0.63, 95 % CI 0.45 – 0.88; p < 0.01). Additionally, more cases in the follow-up group had a follow-up recommendation in the CT report (2.88, 1.95 – 4.26; p < 0.01). A large difference in the frequency of follow-up was noted between the Trauma Unit compared to other units (1.77, 1.09 – 2.89; p < 0.02). This variance is possibly due to the introduction of a dedicated adrenal lesion protocol.

Follow-up arrangements were made for 245 cases (30 %). In 36 % of these cases (N = 88) follow-up occurred at The Alfred Hospital. Seven cases (8 %) required surgical intervention. Histopathology confirmed four adrenal cortical tumours, two metastatic melanomas and one phaeochromocytoma. 

Conclusions: This study highlights that AI follow-up is often overlooked, and that approaches need to be developed to ensure that all cases receive the review they require. This study demonstrates that follow-up is influenced by patient, radiological and medical provider factors. An adrenal lesion follow-up protocol may improve follow-up rates, but requires further research.